Eton Pharmaceuticals Submits New Drug Application to the FDA for Orphan Drug Dehydrated Alcohol Injection (DS-100)GlobeNewsWire • 07/27/20
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/15/20
Eton Pharmaceuticals Inc (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 05/07/20
Eton Pharmaceuticals Confirms First-to-File Patent Challenge on Elcys (Cysteine Hydrochloride Injection)GlobeNewsWire • 05/07/20
Eton Pharmaceuticals, Inc. (ETON) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 04/28/20
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® SprinkleGlobeNewsWire • 03/27/20
Eton Pharmaceuticals, Inc. (ETON) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 03/26/20
Eton Pharmaceuticals Reports Positive Study Results for ET-101 (Topiramate Oral Solution)GlobeNewsWire • 03/17/20
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/06/20
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/05/20
Eton Pharmaceuticals and Xellia Pharmaceuticals Announce Biorphen® (phenylephrine HCl) Co-Promotion AgreementGlobeNewsWire • 01/21/20
Eton Pharmaceuticals Announces Commercial Availability of Biorphen® (phenylephrine HCI) InjectionGlobeNewsWire • 12/02/19
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) InjectionGlobeNewsWire • 10/22/19
Eton Pharmaceuticals to Participate in Lake Street 3rd Annual Best Ideas Growth ConferenceGlobeNewsWire • 09/03/19
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/10/19